HIV-related skin diseases

Lancet

Volumn 348, Issue 9028, 1996, Pages 659-663

  Tschachler, Erwin ^a   Bergstresser, Paul R ^b   Stingl, Georg ^a  

^a Universitatsklinik fur Dermatologie   (Austria)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; COTRIMOXAZOLE; SULFONAMIDE;

BACTERIAL SKIN DISEASE; DERMATOPHYTE; DISEASE COURSE; HEMANGIOMATOSIS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; KAPOSI SARCOMA; MUCOSA; MYCOBACTERIUM; MYCOSIS; PATIENT COUNSELING; PRIORITY JOURNAL; PRURITUS; REVIEW; SKIN DISEASE; SKIN INFECTION; SKIN MANIFESTATION; STAPHYLOCOCCUS AUREUS; SYPHILIS; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; WART VIRUS;

EID: 0030573802     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)01032-X     Document Type: Review

References (45)

1. 1 Coldiron BM, Bergstresser PR. Prevalence and clinical spectrum of skin disease in patients infected with human immunodeficiency virus. Arch Dermatol 1988; 125: 357-61.
2. 2 Stingl G, Hauser C, Wolff K. The epidermis: an immunological microenvironment. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine. New York: McGraw-Hill, 1993: 172-97.
3. 3 Belsito DV, Sanchez MR, Baer R, et al. Reduced Langerhans cell Ia antigen and ATP-ase activity in patients with acquired immunodeficiency syndrome. N Engl J Med 1984; 310: 1279-82.
4. 4 Tschachler E, Groh V, Popovic M, et al. Epidermal Langerhans cells: a target for HTLV-III/LAV infection. J Invest Dermatol 1987; 88: 233-37.
5. 5 Langhoff E, Terwilliger EF, Bos HJ, et al. Replication of human immunodeficiency virus type 1 in primary dendritic cells cultures. Proc Natl Acad Sci USA 1991; 88: 7998-8002.
6. 6 Pope M, Betjes MGH, Romani N, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994; 78: 389-98.
7. 7 Gordin FM, Hartigan PM, Klimas NG, et al. Delayed-type hypersensitivity skin tests are an independent predictor of human immunodeficiency virus disease progression. J Infect Dis 1994; 169: 893-97.
8. 8 Tindall B, Cooper DA. Primary HIV infection: host response and intervention strategies. AIDS 1991; 5: 1-14.
9. 9 Tindall B, Hing M, Edwards P, et al. Severe clinical manifestations of primary HIV infection. AIDS 1989; 3: 747-49.
10. 10 Johnson RA, Dover JS. Cutaneous manifestations of human immunodeficiency virus disease. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, eds. Dermatology in general medicine. New York: McGraw-Hill, 1993: 172-97.
11. 11 Centers for Disease Control. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morbid Mortal Wkly Rep 1993; 41: 1-19 (RR-17).
12. 12 Jura E, Chadwick EG, Josephs SH. Varicella-zoster virus infections in children infected with human immunodeficiency virus. Pediatr Infect Dis J 1989; 8: 586-90.
13. 13 Buchbinder SP, Katz MH, Hessol NA, et al. Herpes zoster and human immunodeficiency virus infection. J Infect Dis 1992; 166: 1153-56.
14. 14 Melbye M, Grossman RJ, Goedert JJ, et al. Risk of AIDS after herpes zoster. Lancet 1987; ii: 728-31.
15. 15 Colebunders R, Mann JM, Fracis H, et al. Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection. J Infect Dis 1989; 157: 314-18.
16. 16 Cohen PR, Grossman ME. Clinical features of human immunodeficiency virus-associated disseminated herpes zoster virus infection: a review of the literature. Clin Exp Dermatol 1989; 14: 273-76.
17. 17 Gulick RM, Heath-Chiozzi M, Crumpacher CS. Varicella-zoster virus disease in patients with human immunodeficiency virus infection. Arch Dermatol 1990; 126: 1086-88.
18. 18 Schwartz JJ, Myskowski PL. Molluscum contagiosum in patients with human immunodeficiency virus infection: a review of twenty-seven patients. J Am Acad Dermatol 1992; 27: 583-88.
19. 19 Fiveson DP, Weltman RE, Gibson SH. Giant molluscum contagiosum presenting as a basal cell carcinoma in an acquired immunodeficiency patient. J Am Acad Dermatol 1988; 29: 912-14.
20. 20 Petry KU, Scheffel D, Bode U, et al. Cellular immunodeficiency enhances the progression of human papillomavirus-associated cervical lesions. Int J Cancer 1994; 57: 836-40.
21. 21 Breese PL, Judson FN, Penley KA, Douglas JM. Anal human papillomavirus infection among homosexual and bisexual men: prevalence of type-specific infection and association with human-immunodeficiency-virus. Sexually Transm Disease 1995; 22: 7-14.
22. 22 Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med 1993; 328: 1670-74.
23. 23 Smith KJ, Wagner KF, Yeager J, et al. Staphylococcus aureus carriage and HIV-1 disease: association with increased mucocutaneous infection as well as deep soft-tissue infections and sepsis. Arch Dermatol 1994; 130: 521-22.
24. 24 Nichols L, Balogh K, Silverman M. Bacterial infections in the acquired immunodeficiency syndrome: clinicopathological correlations in a series of autopsy cases. Am J Clin Pathol 1989; 92: 787-90.
25. 25 Skoutelis AT, Murphy RL, MacDonell KB, et al. Indwelling central venous catheter infections in patients with the acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr 1990; 3: 335-42.
26. 26 Straus WL, Ostroff SM, Jernigan DB, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994; 120: 118-25.
27. 27 Frommel D, Tekle-Haimanot R, Verdier M, et al. HIV infection and leprosy: a four-year survey in Ethiopia. Lancet 1994; 344: 165-66.
28. 28 Gregory N, Sanchez M, Buchness MR. The spectrum of syphilis in patients with human immunodeficiency virus infection. J Am Acad Dermatol 1990; 22: 1061-67.
29. 29 Hutchinson CM, Hook EW, Shepherd M, et al. Altered clinical presentation of early syphilis in patients with human immunodeficiency virus infection. Ann Intern Med 1994; 121: 94-99.
30. 30 Centers for Disease Control. Recommendations for diagnosing and treating syphilis in HIV-infected patients. Morbid Mortal Wkly Rep 1988; 37: 600-08.
31. 31 Slater LS, Welch DR, Kyung-Whan M. Rochalimaea henselae causes bacillary angiomatosis and peliosis hepatis. Arch Intern Med 1992; 152: 602-06.
32. 32 Cockerell CJ, LeBoit PE. Bacillary angiomatosis: a newly characterised, pseudoneoplastic, infectious, cutaneous vascular disorder. J Am Acad Dermatol 1990; 22: 501-12.
33. 33 Smith KJ, Skelton HG, Yeager J, et al. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol 1994; 31: 746-54.
34. 34 Dompmartin D, Dompmartin A, Deluol AM, et al. Onychomycosis and AIDS: clinical and laboratory findings in 62 patients. Int J Dermatol 1990; 29: 337-39.
35. 35 Clark RA, Greer D, Atkinson W, et al. Spectrum of Cryptococcus neoformans infection in 68 patients infected with the human immunodeficiency virus. Rev Infect Dis 1990; 12: 768-77.
36. 36 Durden FM, Elewski B. Cutaneous involvement with Cryptococcus neoformans in AIDS. J Am Acad Dermatol 1994; 30: 844-48.
37. 37 Hilsmarsdottir I, Meynard JL, Rogeaux O, et al. Disseminated Penicillium marneffei infection associated with human immunodeficiency virus and review of 35 published cases. J Acquir Immune Defic Syndr 1993;6: 466-71.
38. 38 Mathes BM, Douglass MC. Sebhorrheic dermatitis in patients with acquired immunodeficiency syndrome. J Am Acad Dermatol 1985; 13: 947-51.
39. 39 Groisser D, Bottone EJ, Lebwohl M. Association of Pityrosporum orbiculare ( Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol 1989; 20: 770-73.
40. 40 Wikler JR, Nieboer C, Willemze R. Quantitative skin cultures of Pityrosporum yeasts in patients seropositive for the human immunodeficiency virus with and without seborrheic dermatitis. J Am Acad Dermatol 1992; 27: 37-39.
41. 41 Solinger AM, Hess EV. Rheumatic diseases and AIDS: is the association real? J Rheumatol 1993; 20: 678-83.
42. 42 Laiutaud B, Pape JW, DeHovitz JA, et al. Pruritic skin lesions: a common initial presentation of acquired immunodeficiency syndrome. Arch Dermatol 1989; 125: 629-32.
43. 43 Rosenthal D, LeBoit PE, Klumpp L, Berger TG. human immunodeficiency virus-associated eosinophilic folliculitis: a unique dermatosis associated with advanced human immunodeficiency virus infection. Arch Dermatol 1991; 127: 206-09.
44. 44 Porteous DM, Berger TG. Severe cutaneous drug reactions (Stevens-Johnson syndrome and toxic epidermal necrolysis) in human immunodeficiency virus infection. Arch Dermatol 1991; 127: 740-41.
45. 45 Saiag P, Caumes E, Chosidow O, et al. Drug-induced toxic epidermal necrolysis (Lyell syndrome) in patients infected with the human immunodeficiency virus. J Am Acad Dermatol 1992; 26: 567-74.